Redefining pharma containers for enhanced inclusion: improving usability and therapy adherence for patients with disabilities and elderly individuals

Innovation Manager at Bormioli Pharma, Italy


The percentage of people with forms of disability is growing all over the world. That’s why inclusion is becoming a paradigm of innovation in several industries, with the development of specifically designed concepts. Pharma is no exception in this trend, with companies and packaging manufacturers strongly committed in improving autonomy and therapy adherence for this category. Bormioli Pharma is among the industry players that are presenting concepts addressing these accessibility growing needs for oral liquid drugs.

Today, one in ten people in the world has some form of disability. That is what emerges from the latest estimates by the United Nations, according to which there are approximately 650 million people with disabilities worldwide. About 80% of them live in developing countries, where one-third of school-age children have a disability. As the world’s population ages, the number of people with disabilities is destined to continuously increase.


In the European Union, the percentage of people with disabilities is estimated by the European Disability Forum to be between 10 and 15%, out of a total of at least 50 million people across the 27 EU Member States. Most of them – according to the Italian National Statistics Institute - are aged 75 or over, and strongly rely on their families for everyday support in their lives. Latest estimates by the same body show that the number of caregivers supporting non self-sufficient family members aged 15 or over stands at 2.8 million people, mostly women aged 45 to 55 who have often left their job to assist relatives, and are committed to this task for up to 18 hours a day. In half of the cases, they could also not rely on ...